338 related articles for article (PubMed ID: 31170928)
1. Lack of association between methylenetetrahydrofolate reductase C677T polymorphism, HPV infection and cervical intraepithelial neoplasia in Brazilian women.
Silva NNT; Sabino AP; Tafuri A; Lima AA
BMC Med Genet; 2019 Jun; 20(1):100. PubMed ID: 31170928
[TBL] [Abstract][Full Text] [Related]
2. MTHFR/p53 polymorphisms as genetic factors for cervical intraepithelial neoplasia and cervical cancer in HPV-infected Mexican women.
González-Herrera L; Rodríguez-Morales P; Gonza Lez-Losa Mdel R; Pérez-Mendoza G; Canul-Canché J; Rosado-López I; Cetina TC
Int J Biol Markers; 2014 Jun; 29(2):e142-9. PubMed ID: 24474455
[TBL] [Abstract][Full Text] [Related]
3. MTHFR C677T polymorphism was an ethnicity-dependent risk factor for cervical cancer development: evidence based on a meta-analysis.
Wu CY; Yang M; Lin M; Li LP; Wen XZ
Arch Gynecol Obstet; 2013 Sep; 288(3):595-605. PubMed ID: 23463325
[TBL] [Abstract][Full Text] [Related]
4. The effect of methylenetetrahydrofolate reductase polymorphisms on susceptibility to human papilloma virus infection and cervical cancer.
Hajiesmaeil M; Tafvizi F; Sarmadi S
Infect Genet Evol; 2016 Dec; 46():1-6. PubMed ID: 27771518
[TBL] [Abstract][Full Text] [Related]
5. Association between MTHFR C677T, MTHFR A1298C and MS A2756G polymorphisms and risk of cervical intraepithelial neoplasia II/III and cervical cancer: a meta-analysis.
Zhu J; Wu L; Kohlmeier M; Ye F; Cai W
Mol Med Rep; 2013 Sep; 8(3):919-27. PubMed ID: 23864153
[TBL] [Abstract][Full Text] [Related]
6. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and promoter methylation in cervical oncogenic lesions and cancer.
Botezatu A; Socolov D; Iancu IV; Huica I; Plesa A; Ungureanu C; Anton G
J Cell Mol Med; 2013 Apr; 17(4):543-9. PubMed ID: 23444906
[TBL] [Abstract][Full Text] [Related]
7. A lower degree of PBMC L1 methylation in women with lower folate status may explain the MTHFR C677T polymorphism associated higher risk of CIN in the US post folic acid fortification era.
Badiga S; Johanning GL; Macaluso M; Azuero A; Chambers MM; Siddiqui NR; Piyathilake CJ
PLoS One; 2014; 9(10):e110093. PubMed ID: 25302494
[TBL] [Abstract][Full Text] [Related]
8. Investigation of Methylenetetrahydrofolate Reductase C677T Polymorphism and Human Papilloma Virus Genotypes in Iranian Breast Cancer.
Rezaei H; Rassi H; Mansur FN
Monoclon Antib Immunodiagn Immunother; 2017 Jun; 36(3):124-128. PubMed ID: 28537481
[TBL] [Abstract][Full Text] [Related]
9. Association of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism with primary glaucoma in Saudi population.
Al-Shahrani H; Al-Dabbagh N; Al-Dohayan N; Arfin M; Al-Asmari M; Rizvi S; Al-Asmari A
BMC Ophthalmol; 2016 Sep; 16(1):156. PubMed ID: 27585654
[TBL] [Abstract][Full Text] [Related]
10. Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to cervical cancer and cervical intraepithelial neoplasia: a meta-analysis.
Luo YL; Ye P; Zhang QH; Hu TT; Luo MH; Li MQ; Chen Q
PLoS One; 2012; 7(9):e46272. PubMed ID: 23029458
[TBL] [Abstract][Full Text] [Related]
11. The association between MTHFR polymorphism and cervical cancer.
Gong JM; Shen Y; Shan WW; He YX
Sci Rep; 2018 May; 8(1):7244. PubMed ID: 29740106
[TBL] [Abstract][Full Text] [Related]
12. Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia.
Goodman MT; McDuffie K; Hernandez B; Wilkens LR; Bertram CC; Killeen J; Le Marchand L; Selhub J; Murphy S; Donlon TA
Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1275-80. PubMed ID: 11751445
[TBL] [Abstract][Full Text] [Related]
13. Association between Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to cervical cancer: a meta-analysis.
Yu L; Chang K; Han J; Deng S; Chen M
PLoS One; 2013; 8(2):e55835. PubMed ID: 23431363
[TBL] [Abstract][Full Text] [Related]
14. Distribution of p53, GST, and MTHFR polymorphisms and risk of cervical intraepithelial lesions in sicily.
Agodi A; Barchitta M; Cipresso R; Marzagalli R; La Rosa N; Caruso M; Castiglione MG; Travali S
Int J Gynecol Cancer; 2010 Jan; 20(1):141-6. PubMed ID: 20130515
[TBL] [Abstract][Full Text] [Related]
15. The effect of methylenetetrahydrofolate reductase polymorphism C677T on cervical cancer in Korean women.
Sull JW; Jee SH; Yi S; Lee JE; Park JS; Kim S; Ohrr H
Gynecol Oncol; 2004 Dec; 95(3):557-63. PubMed ID: 15581963
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants of the dUTPase-encoding gene DUT increase HR-HPV infection rate and cervical squamous cell carcinoma risk.
Ye F; Wang H; Liu J; Cheng Q; Chen X; Chen H
Sci Rep; 2019 Jan; 9(1):513. PubMed ID: 30679536
[TBL] [Abstract][Full Text] [Related]
17. Methylenetetrahydrofolate reductase (MTHFR) polymorphism increases the risk of cervical intraepithelial neoplasia.
Piyathilake CJ; Macaluso M; Johanning GL; Whiteside M; Heimburger DC; Giuliano A
Anticancer Res; 2000; 20(3A):1751-7. PubMed ID: 10928104
[TBL] [Abstract][Full Text] [Related]
18. Development of cervical intraepithelial lesions and cervical cancer is not influenced by SOD2 RS4880 polymorhism.
Curti RRJ; Castilha EP; Bonaldo ALL; Okuyama NCM; Trugilo KP; Guembarovski RL; Couto-Filho JD; Watanabe MAE; de Oliveira KB
Pathol Res Pract; 2022 Feb; 230():153742. PubMed ID: 34959097
[TBL] [Abstract][Full Text] [Related]
19. Methylenetetrahydrofolate reductase polymorphism C677T is not associated to the risk of cervical dysplasia.
Lambropoulos AF; Agorastos T; Foka ZJ; Chrisafi S; Constantinidis TC; Bontis J; Kotsis A
Cancer Lett; 2003 Mar; 191(2):187-91. PubMed ID: 12618332
[TBL] [Abstract][Full Text] [Related]
20. Allele and Genotype Frequencies of the Polymorphic Methylenetetrahydrofolate Reductase and Lung Cancer in ther Jordanian Population: a Case Control Study.
Al-Motassem Y; Shomaf M; Said I; Berger S; Ababneh N; Diab O; Obeidat N; Awidi A
Asian Pac J Cancer Prev; 2015; 16(8):3101-9. PubMed ID: 25921104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
